The Prostate · 2006 · 171 citations · 44 references
Life SciencesCell BiologyOncologyCell SignalingMetastasisSignal TransductionAdhesion MoleculesCancer Cell SignalingCell Adhesion ReceptorsCell-cell AdhesionIntegrin SignalingMetastatic Signaling PathwaysAdhesion ReceptorsCancer Cell-cell AdhesionCell Adhesion Receptor BindingIntegrin Signaling In CancerIntegrin-mediated Cell AdhesionMetastatic MechanismsMetastatic SignalingWestern Blotting
BACKGROUND: Stromal cell-derived factor-1 (SDF-1 or CXCL12) and CXCR4 are key elements in the metastasis of prostate cancer cells to bone--but the mechanisms as to how it localizes to the marrow remains unclear. METHODS: Prostate cancer cell lines were stimulated with SDF-1 and evaluated for alterations in the expression of adhesion molecules using microarrays, FACs, and Western blotting to identify alpha(v)beta(3) receptors. Cell-cell adhesion and invasion assays were used to verify that activation of the receptor is responsive to SDF-1. RESULTS: We demonstrate that SDF-1 transiently regulates the number and affinity of alpha(v)beta(3) receptors by prostate cancer cells to enhance their metastatic behavior by increasing adhesiveness and invasiveness. SDF-1 transiently increased the expression of beta(3) receptor subunit and increased its phosphorylation in metastatic but not nonmetastatic cells. CONCLUSIONS: The transition from a locally invasive phenotype to a metastatic phenotype may be primed by the elevated expression of alpha(v)beta(3) receptors. Activation and increased expression of alpha(v)beta(3) within SDF-1-rich organs may participate in metastatic localization.
44
Involvement of chemokine receptors in breast cancer metastasis
Anja Müller, Bernhard Homey, Hortensia Soto et al. · Nature · 2001 · 5.3K citations
Medicine, Cancer Biology, Oncology +14
Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development
Yong-Rui Zou, Andreas H. Kottmann, Masahiko Kuroda et al. · Nature · 1998 · 2.5K citations
Chemokine receptor CXCR4 downregulated by von Hippel–Lindau tumour suppressor pVHL
Peter Staller, Jitka Sulitkova, Joanna Lisztwan et al. · Nature · 2003 · 865 citations · Full text
Medicine, Immunology, Oncology +12
Tumor Regression by Targeted Gene Delivery to the Neovasculature
John Hood, Mark D. Bednarski, Ricardo F. Frausto et al. · Science · 2002 · 858 citations
Pharmacy, Oncology, Pharmaceutics +17